BioMarin Pharmaceutical
NASDAQ: BMRN $66.53 USD
Global biotechnology company developing and commercializing innovative therapies for rare genetic diseases.
Company Info
Recent News
No recent news updates available for this company.
Global biotechnology company developing and commercializing innovative therapies for rare genetic diseases.
No recent news updates available for this company.